Bovine Trypanosomiasis Study Guide
Overview and Clinical Importance
African Animal Trypanosomiasis (AAT), also known as nagana, is a devastating protozoan disease of cattle caused by several species of Trypanosoma transmitted primarily by tsetse flies (Glossina spp.). This disease represents one of the most significant constraints on livestock production in sub-Saharan Africa, causing annual economic losses estimated at over 1 billion USD.
The disease is characterized by intermittent fever, progressive anemia, weight loss, and lymphadenopathy. Trypanosomiasis affects the hemic and lymphatic systems through complex mechanisms involving immune-mediated hemolysis, erythrophagocytosis, and lymphoid hyperplasia followed by depletion.
Etiology and Classification
Bovine trypanosomiasis is caused by flagellated protozoan parasites of the genus Trypanosoma. The three most important species affecting cattle in Africa are:
Major Trypanosome Species in Cattle
Epidemiology and Transmission
Geographic Distribution
Tsetse-transmitted trypanosomiasis is endemic in sub-Saharan Africa, affecting approximately 10 million square kilometers across 37 countries. The distribution is determined by tsetse fly habitat, which includes woodland savannas, riverine forests, and gallery forests.
T. vivax has extended beyond Africa to South America and the Caribbean, where it is transmitted mechanically by biting flies (tabanids, Stomoxys) in the absence of tsetse.
Vector Biology: Tsetse Flies
Tsetse flies (genus Glossina) are the biological vectors for African trypanosomes. Key characteristics include:
- Both male and female flies are obligate blood feeders
- Viviparous reproduction - females deposit fully developed larvae
- Feed every 2-3 days on vertebrate hosts
- Lifespan of 1-3 months, producing 8-12 offspring
Major Tsetse Fly Species and Habitats
Transmission Cycle
Cyclical transmission occurs through tsetse flies:
- Tsetse ingests bloodstream trypomastigotes during blood meal on infected host
- Parasites transform to procyclic forms in fly midgut and multiply
- Migration to mouthparts (T. vivax, T. congolense) or salivary glands (T. brucei)
- Development of infective metacyclic trypomastigotes (3-4 weeks)
- Injection of metacyclics into new host during subsequent blood meal
Pathophysiology
Mechanisms of Anemia
Anemia is the hallmark clinical feature of bovine trypanosomiasis. Multiple mechanisms contribute:
Antigenic Variation and Immune Evasion
African trypanosomes evade host immunity through antigenic variation of their Variable Surface Glycoprotein (VSG) coat. Key points:
- VSG coat covers entire parasite surface (10 million copies per cell)
- Genome contains approximately 1,000 VSG genes
- Parasites can switch to new VSG type before immune clearance
- Results in waves of parasitemia (relapsing pattern)
- Makes vaccine development extremely challenging
Effects on Lymphoid System
Trypanosomiasis causes profound changes to lymphoid tissue:
- Early infection: Lymphoid hyperplasia with B-cell proliferation and hypergammaglobulinemia
- Chronic infection: Lymphoid depletion and profound immunosuppression
- Splenomegaly: Due to erythrophagocytosis and extramedullary hematopoiesis
- Lymphadenopathy: Particularly superficial lymph nodes (prescapular, prefemoral)
Clinical Signs and Presentation
The incubation period is typically 1-4 weeks. Disease presentation varies from acute to chronic depending on trypanosome species, virulence, and host factors.
Clinical Signs by System
Diagnosis
Parasitological Methods
Direct parasite detection remains the gold standard for diagnosis:
Serological and Molecular Methods
- ELISA (antibody detection): Useful for herd screening; remains positive after treatment
- Antigen-ELISA: Detects circulating antigens; greater than 90% sensitivity; becomes negative after successful treatment
- PCR: Highest sensitivity; species-specific; limited field availability
- CATT (Card Agglutination Test): Rapid field test; primarily for T. brucei group
Hematological Findings
Laboratory abnormalities in bovine trypanosomiasis include:
- Anemia: PCV commonly falls to 15-20% (normal 24-46%); initially regenerative, becomes non-regenerative
- Leukopenia: Lymphopenia and neutropenia common
- Thrombocytopenia: Contributes to hemorrhagic tendencies in acute T. vivax
- Hypergammaglobulinemia: Polyclonal B-cell activation; IgM markedly elevated
- Hypoalbuminemia: Due to chronic inflammation and protein loss
Treatment
Only a limited number of trypanocidal drugs are available. All have narrow therapeutic indices, making accurate dosing essential.
Trypanocidal Drugs for Cattle
Prevention and Control
Vector Control Strategies
Trypanotolerant Cattle
Certain West African Bos taurus breeds exhibit trypanotolerance - an innate ability to remain productive despite trypanosome infection:
Differential Diagnosis
The non-specific clinical signs of trypanosomiasis overlap with several other conditions:
- Anaplasmosis: Hemolytic anemia with fever; RBC inclusions on blood smear
- Babesiosis: Hemolytic anemia, hemoglobinuria; intraerythrocytic piroplasms visible
- Theileriosis: Lymphadenopathy, anemia; Koch's blue bodies in lymphocytes; schizonts in lymph node smears
- Chronic fasciolosis: Weight loss, anemia; submandibular edema; eggs on fecal exam
- Haemonchosis: Anemia in small ruminants/young cattle; bottle jaw; eggs on fecal exam
- Malnutrition/starvation: Weight loss without fever; no parasitemia; history of feed shortage
Prognosis
- Untreated: Usually fatal in susceptible breeds; chronic debilitation with eventual death
- Treated early: Good prognosis; PCV recovery within 2-4 weeks; productivity resumes
- Chronic/advanced cases: Guarded; may clear infection but permanent organ damage possible
- Drug-resistant infections: Poor unless alternative effective drug available
Zoonotic Considerations
T. brucei rhodesiense, which causes acute human African trypanosomiasis (East African sleeping sickness), can use cattle as a reservoir host. Key points:
- Cattle may carry T. b. rhodesiense asymptomatically while serving as a source of human infection
- Mass treatment of cattle with trypanocides has been used as a One Health intervention to reduce human sleeping sickness
- T. congolense and T. vivax are NOT zoonotic - they do not infect humans
Practice NAVLE Questions
Test your knowledge with 10,000+ exam-style questions, detailed explanations, and timed exams.
Start Your Free Trial →